SOS1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, the TAM-induced ablation of SOS1 after 8 months of age, when CML was already significantly developed in the transgenic mice, did not produce any significant delay in the disease (Figure 2B).